Tag: Alzheimer’s disease

June 25, 2019

Anavex Life Sciences Doses First Patient in Extension Study to US Phase 2 Clinical Trial of ANAVEX2-73

Anavex Life Sciences (NASDAQ:AVXL) has announced that the first patient that completed the Phase 2 clinical trial ANAVEX2-73-RS-001 has moved...